Results 51 to 60 of about 1,999,014 (306)

Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review

open access: yesInternational Journal of Molecular Sciences, 2019
Almost all patients with hepatocellular carcinoma (HCC), a major type of primary liver cancer, also have liver cirrhosis, the severity of which hampers effective treatment for HCC despite recent progress in the efficacy of anticancer drugs for advanced ...
T. Kanda   +4 more
semanticscholar   +1 more source

Usefulness of Carnitine Supplementation for the Complications of Liver Cirrhosis

open access: yesNutrients, 2020
Carnitine is a vitamin-like substance that regulates lipid metabolism and energy production. Carnitine homeostasis is mainly regulated by dietary intake and biosynthesis in the organs, including the skeletal muscle and the liver.
T. Hanai   +5 more
semanticscholar   +1 more source

Learning to diagnose cirrhosis from radiological and histological labels with joint self and weakly-supervised pretraining strategies [PDF]

open access: yesarXiv, 2023
Identifying cirrhosis is key to correctly assess the health of the liver. However, the gold standard diagnosis of the cirrhosis needs a medical intervention to obtain the histological confirmation, e.g. the METAVIR score, as the radiological presentation can be equivocal.
arxiv  

Correlation of Serum Cardiac Markers with Acute Decompensating Events in Liver Cirrhosis

open access: yesGastroenterology Research and Practice, 2020
Background and Aim. Liver cirrhosis is often accompanied by insidious cardiac dysfunction. This retrospective cross-sectional study is aimed at exploring the correlation between serum cardiac markers and decompensating events in liver cirrhosis. Methods.
Miaomiao Li   +10 more
doaj   +1 more source

Assessment and validation of the TREAT-B score to assess the treatment eligibility of patients with chronic hepatitis B virus infection

open access: yesFrontiers in Medicine, 2022
Background and aimsAccess to Hepatitis B virus (HBV) DNA testing to determine treatment eligibility is limited in low-income countries. Therefore, this study aimed to assess and validate the TREAT-B score proposed as the treatment threshold in an Asian ...
Kessarin Thanapirom   +13 more
doaj   +1 more source

The Characteristics Variation of Hepatic Progenitors after TGF-β1-Induced Transition and EGF-Induced Reversion

open access: yesStem Cells International, 2016
Profibrogenesis cytokine, transforming growth factor- (TGF-) β1, induces hepatic progenitors experiencing epithelial to mesenchymal transition (EMT) to matrix synthesis cells, even tumor initiating cells.
Ping Wang   +11 more
doaj   +1 more source

HFE-Related Hemochromatosis in a Chinese Patient: The First Reported Case

open access: yesFrontiers in Genetics, 2020
HFE-related Hemochromatosis is the most common genetic iron overload disease in European populations, particularly of Nordic or Celtic ancestry.
Wei Zhang   +28 more
doaj   +1 more source

Noninvasively Assessed Portal Hypertension Grade Predicts Post-Hepatectomy Liver Failure in Patients With HepatocellCarcinoma: A Multicenter Study

open access: yesFrontiers in Oncology, 2022
PurposeTo determine the predictive value of portal hypertension (PH) for the development of post-hepatectomy liver failure (PHLF) in patients with hepatocellular carcinoma (HCC).Patients and methodsThis study enrolled a total of 659 patients with HCC ...
Jitao Wang   +15 more
doaj   +1 more source

Burden of Liver Cirrhosis in Portugal between 2010 and 2017 [PDF]

open access: yes, 2021
This work was produced with the support of INCD funded by FCT and FEDER under the project 01/SAICT/2016 No. 022153.Introduction: Liver cirrhosis is a prevalent disease in Portugal.
Calinas, Filipe   +3 more
core   +3 more sources

Autologous Bone Marrow Infusion Activates the Progenitor Cell Compartment in Patients with Advanced Liver Cirrhosis

open access: yesCell Transplantation, 2010
Several clinical trials of bone marrow cell infusion in patients with liver cirrhosis (LC) have shown clinical improvement, despite conflicting results from animal models.
Ja Kyung Kim   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy